ASSOCIATION BETWEEN INSULIN RESISTANCE LEVEL AND LIPID PROFILE IN PATIENTS WITH OBESITY
DOI:
https://doi.org/10.55640/Keywords:
obesity, insulin resistance, HOMA-IR, dyslipidemia, lipid profile.Abstract
Obesity is one of the most pressing problems of modern medicine, increasing the risk of metabolic syndrome, type 2 diabetes mellitus, and cardiovascular diseases. The aim of this study was to determine the relationship between the degree of insulin resistance and lipid profile parameters in patients with obesity. A total of 80 patients with obesity participated in the study. Body mass index (BMI), fasting glucose, insulin levels, and lipid profile were measured in all participants, and insulin resistance was assessed using the HOMA-IR index. The results showed that the HOMA-IR index was positively correlated with triglyceride and LDL levels and negatively correlated with HDL levels (p<0.05). The findings confirm that insulin resistance plays an important role in the development of dyslipidemia in obesity.
Downloads
References
1.World Health Organization. Obesity and Overweight. Geneva; 2023.
2.American Diabetes Association. Standards of Care in Diabetes—2024. Diabetes Care. 2024.
3.International Diabetes Federation. IDF Diabetes Atlas. 10th ed. 2021.
4.Gerald M. Reaven. Insulin resistance and cardiovascular disease. New England Journal of Medicine. 1988.
5.Scott M. Grundy. Metabolic syndrome update. Circulation. 2005.
6.Steven E. Kahn et al. Mechanisms linking obesity to insulin resistance. Nature. 2006.
7.Harold E. Bays. Adiposopathy and metabolic disease. Current Opinion in Endocrinology. 2014.
8.Marie A. Cornier et al. The metabolic syndrome. Endocrine Reviews. 2008.
9.Henry N. Ginsberg. Insulin resistance and dyslipidemia. Journal of Clinical Investigation. 2000.
10.Ralph A. DeFronzo. Pathogenesis of insulin resistance. Diabetes. 2009.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

Germany
United States of America
Italy
United Kingdom
France
Canada
Uzbekistan
Japan
Republic of Korea
Australia
Spain
Switzerland
Sweden
Netherlands
China
India